Abstract

BackgroundHyperoside (Hyp) is a flavonoid substance extracted from plants, which has the functions of anti-cancer, anti-inflammatory, and anti-oxidation. In the previous study, we found that Hyp reduced the injury of rat retinal vascular endothelial cells (RVECs) induced by H2O2.MethodIn the present research, we evaluated the protective effect of Hyp on the pathological damage of retina caused by high glucose of diabetes mellitus (DM) in in vitro and in vivo experiments. The effect of Hyp on cell viability, oxidative stress level, and apoptosis of RVECs was assessed.ResultsHyp significantly reduced the of RVECs damage, oxidative stress level, and cell apoptosis induced by high glucose in vitro. In DM model rats, Hyp treatment could significantly reduce blood glucose levels and the pathological damage of retina caused by DM and increase the proliferation of RVECs while exerting the inhibition on apoptotic activity. Furthermore, Hyp treatment decreased the expressions of apoptotic proteins including caspase-3, caspase-9, and Bax in RVECs of DM rats, while increased the expression of anti-apoptotic protein Bcl-2.ConclusionHyp may have protective effect on diabetes-induced retinopathy by reducing oxidative stress, inhibiting cell damage, and apoptosis induced by high glucose.

Highlights

  • Diabetes is a metabolic disease which can lead to systematic complications including retinopathy, cardiovascular complications, and diabetic nephropathy

  • In the present study, using a rat STZ–induced diabetic retinopathy model and rat retinal vascular endothelial cells, we initially investigated the therapeutic effect of Hyp on ameliorating the diabetes-induced damage of retinas

  • Our results showed that Hyp had the potential protective effects on diabetic retinopathy through anti-oxidation, inhibiting cell damage and apoptosis of retinal vascular endothelial cells (RVECs) induced by high glucose

Read more

Summary

Introduction

Diabetes is a metabolic disease which can lead to systematic complications including retinopathy, cardiovascular complications, and diabetic nephropathy. Calcium dobesilate, which is an established vasoactive and angioprotective drug, has been used to treat diabetic retinopathy at the systematic and local ocular level with promising results (Haritoglou et al, 2009; Cai et al, 2017). These drugs may Hyperoside Ameliorates Diabetic Retinopathy show some side effects, and not all patients respond to antiVEGF agents. The effect of Hyp on cell viability, oxidative stress level, and apoptosis of RVECs was assessed

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call